ACE inhibitors: over two decades of use.
During the meeting of the American Society of Hypertension, Inc. in San Francisco, CA, on May 16, 2005, a roundtable was convened to discuss angiotensin-converting enzyme inhibition as it relates to both blood pressure control and issues of end-organ protection. Dr. Domenic A. Sica of Virginia Commonwealth University, Richmond, VA, moderated the panel discussion. Participants included Dr. Thomas D. Giles of the Louisiana State University Health Sciences Center, New Orleans, LA, and President of The American Society of Hypertension, Inc.; Dr. Henry R. Black of Rush University Medical Center, Chicago, IL; and Dr. Vito M. Campese of the University of Southern California, Los Angeles, CA.
Sica
Domenic A
DA
Virginia Commonwealth University, Richmond, VA, USA.
Giles
Thomas D
TD
Black
Henry R
HR
Campese
Vito M
VM
D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use*; D001794:Blood Pressure / Q000187:drug effects; D002561:Cerebrovascular Disorders / Q000517:prevention & control; D003920:Diabetes Mellitus / Q000517:prevention & control; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D007674:Kidney Diseases / Q000473:pathology / Q000517:prevention & control
D000806:Angiotensin-Converting Enzyme Inhibitors